Literature DB >> 22236332

Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell lines.

E L Seiser1, R Thomas, K L Richards, M Kathryn Kelley, P Moore, S E Suter, M Breen.   

Abstract

Molecular characterization of tumour cell lines is increasingly regarded as a prerequisite for defining their validity as models of in vivo neoplasia. We present the first comprehensive catalogue of genomic and transcriptional characteristics of five widely used canine lymphoid tumour cell lines. High-resolution microarray-based comparative genomic hybridization defined their unique profiles of genomic DNA copy number imbalance. Multicolour fluorescence in situ hybridization identified aberrant gains of MYC, KIT and FLT3 and deletions of PTEN and CDKN2 in individual cell lines, and also revealed examples of extensive structural chromosome reorganization. Gene expression profiling and RT-PCR analyses defined the relationship between genomic imbalance and transcriptional dysregulation in each cell line, clarifying their relevance as models of discrete functional pathways with biological and therapeutic significance. In combination, these data provide an extensive resource of molecular data for directing the appropriate use of these cell lines as tools for studying canine lymphoid neoplasia.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22236332     DOI: 10.1111/j.1476-5829.2011.00299.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  11 in total

1.  Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.

Authors:  Rachael Thomas; Eric L Seiser; Alison Motsinger-Reif; Luke Borst; Victor E Valli; Kathryn Kelley; Steven E Suter; David Argyle; Kristine Burgess; Jerold Bell; Kerstin Lindblad-Toh; Jaime F Modiano; Matthew Breen
Journal:  Leuk Lymphoma       Date:  2011-03-07

2.  Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.

Authors:  Sunetra Das; Rupa Idate; Kathryn E Cronise; Daniel L Gustafson; Dawn L Duval
Journal:  Mol Cancer Ther       Date:  2019-06-07       Impact factor: 6.261

Review 3.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

4.  The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.

Authors:  J S Fowles; D D Dailey; D L Gustafson; D H Thamm; D L Duval
Journal:  Vet Comp Oncol       Date:  2016-05-19       Impact factor: 2.613

5.  Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells.

Authors:  Marie-Ève Nadeau; Charlène Rico; Mayra Tsoi; Mélanie Vivancos; Sabin Filimon; Marilène Paquet; Derek Boerboom
Journal:  BMC Cancer       Date:  2015-06-24       Impact factor: 4.430

6.  A novel canine kidney cell line model for the evaluation of neoplastic development: karyotype evolution associated with spontaneous immortalization and tumorigenicity.

Authors:  R Omeir; R Thomas; B Teferedegne; C Williams; G Foseh; J Macauley; L Brinster; J Beren; K Peden; M Breen; A M Lewis
Journal:  Chromosome Res       Date:  2015-05-10       Impact factor: 5.239

7.  Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.

Authors:  K Meichner; J E Fogle; L English; S E Suter
Journal:  J Vet Intern Med       Date:  2016-03-25       Impact factor: 3.333

8.  Comprehensive genomic characterization of five canine lymphoid tumor cell lines.

Authors:  Sarah C Roode; Daniel Rotroff; Kristy L Richards; Peter Moore; Alison Motsinger-Reif; Yasuhiko Okamura; Takuya Mizuno; Hajime Tsujimoto; Steven E Suter; Matthew Breen
Journal:  BMC Vet Res       Date:  2016-09-17       Impact factor: 2.741

9.  Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation.

Authors:  Leila Taher; Julia Beck; Wen Liu; Catrin Roolf; Jan T Soller; Barbara C Rütgen; Sabine E Hammer; Murali Chodisetti; Sina Sender; Katharina A Sterenczak; Georg Fuellen; Christian Junghanss; Bertram Brenig; Ingo Nolte; Ekkehard Schütz; Hugo Murua Escobar
Journal:  Sci Rep       Date:  2018-04-19       Impact factor: 4.379

10.  6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.

Authors:  Brian K Flesner; Senthil R Kumar; Jeffrey N Bryan
Journal:  BMC Vet Res       Date:  2014-12-06       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.